$25.780
-0.394 (-1.53%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
AKTS-Prognose durch Analyse ähnlicher Charts
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.81 (+0.10%). The 1-week path is $26.11 (+1.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Aktis Oncology Inc-Aktien kaufen?
Aktis Oncology (AKTS) is a good buy right now due to its current price of $25.78, which is significantly lower than the analyst price target of $40 set by Raymond James, indicating a potential upside of 55%. Additionally, the stock has shown a positive momentum with a 5-day change of +7.10% and a 20-day change of +16.81%. The main risk is the negative net income reported at -24,144,000 USD for Q2 2026, which reflects ongoing financial challenges.
AKTS schloss am Friday bei $25.78, nachdem der Kurs -1.53% fallen
Aktis Oncology Inc (AKTS) last closed at $25.78, losing -1.53%. These facts feed the 1-day and 1-week AKTS price prediction above.
Analystenkonsens
Aktis Oncology Inc (AKTS): 3 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Aktis Oncology Inc (AKTS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf AKTS am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für AKTS
Historically the probability of a positive August return for AKTS is 45.24%. July offers the highest probability of a positive month at 45.45%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.